About KeriCure
KeriCure is a company based in Tampa (United States) founded in 2011. KeriCure has raised $800 thousand across 3 funding rounds from investors including Quake Capital. KeriCure offers products and services including Natural Seal® Liquid Bandage, Natural Shield® Silver Liquid Bandage, Moisturizing Hand Sanitizer, Tough Seal® Liquid Bandage, and Champion Shield® Silver Liquid Bandage. KeriCure operates in a competitive market with competitors including Adocia, Imbed Biosciences, Cresilon, Ilya Pharma and QBiotics, among others.
- Headquarter Tampa, United States
-
Sectors
HealthcareTechnology Aerospace, Defense & Maritime
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kericure Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$800 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KeriCure
KeriCure offers a comprehensive portfolio of products and services, including Natural Seal® Liquid Bandage, Natural Shield® Silver Liquid Bandage, Moisturizing Hand Sanitizer, Tough Seal® Liquid Bandage, and Champion Shield® Silver Liquid Bandage.
Spray-on protection for cuts and scrapes to prevent infection.
Antimicrobial spray for healing burns and skin conditions.
Sanitizing spray that moisturizes skin and kills germs.
Durable spray for pet wounds and hotspots.
Advanced spray for comprehensive skin protection.
People of KeriCure
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of KeriCure
KeriCure has successfully raised a total of $800K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in KeriCure
KeriCure has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Quake Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are supported through venture capital investments.
|
Locked | Locked | Locked |
Investor details for KeriCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KeriCure
Investment portfolio details for KeriCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KeriCure
Detailed financials for KeriCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kericure Comparisons
Peer comparison for KeriCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KeriCure
KeriCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Imbed Biosciences, Cresilon, Ilya Pharma and QBiotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
Detailed competitors of KeriCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kericure
Complete news archive for KeriCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KeriCure
KeriCure was founded in 2011 and raised its 1st funding round 1 year after it was founded.
KeriCure is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
KeriCure is a funded company, having raised a total of $800K across 3 funding rounds to date.
KeriCure was founded in 2011 in Tampa, United States, as a developer in the medical products sector. Topical wound care solutions are created for patients, consumers, and military personnel. Key offerings include Quick Seal, a water-based liquid bandage, and Advanced Seal, an aqueous hydrogel designed for infection prevention and pain relief. Pet care products are also produced, with operations focused on aqueous-based formulations.
KeriCure's top competitors include Imbed Biosciences, Adocia and Ilya Pharma.
KeriCure offers Natural Seal® Liquid Bandage, Natural Shield® Silver Liquid Bandage, Moisturizing Hand Sanitizer, Tough Seal® Liquid Bandage, and Champion Shield® Silver Liquid Bandage.
KeriCure has 1 investor. Key investors include Quake Capital.